Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: Relationship between structure and activity

Nutrition and Cancer

Volumn 49, Issue 2, 2004, Pages 191-199

  Yáñez, Josefa ^a   Vicente, Vicente ^a   Alcaraz, Miguel ^a   Castillo, Julián ^b   Benavente García, Obdulio ^b   Canteras, Manuel ^a   Lozano Teruel, José A ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b 80320 Alcantarilla   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BAICALEIN; CATECHIN; FLAVONOID; GALLIC ACID; HYDROXYL GROUP; LUTEOLIN; MYRICETIN; POLYMER; POLYPHENOL DERIVATIVE; QUERCETIN; TANGERETIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL LINE; CELL VIABILITY; CORRELATION ANALYSIS; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; MOUSE; NONHUMAN; OXIDATION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANIMALIA;

EID: 8444228130     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4902_11     Document Type: Article

References (62)

1. Benavente-García O, Castillo J, Marín FR, Ortuño A, and Del Rio JA: Uses and properties of citrus flavonoids. J Agric Food Chem 45, 4505-4515, 1997.
2. Middleton E Jr, Kandaswami C, and Theoharides TC: The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751, 2000.
3. Martínez-Valverde I, Periago MJ, and Ros G: Significado nutricional de los compuestos fenolicos en la dieta. Arch Latinoam Nutr 50, 5-18, 2000.
4. Harborne JB (ed.): The Flavonoids: Advances in Research Since 1986. London: Chapman Hall, 1993.
5. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP, et al.: Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch Biochem Biophys 322, 339-346, 1995.
6. Scalbert A and Williamson G: Dietary intake and bioavailability of polyphenols. J Nutr 130, 2073S-85S, 2000.
7. Hertog MGL, Kromhout D, Aravanis C, Blackburn H, Buzina R, et al.: Flavonoids intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch Intern Med 155, 381-386, 1995.
8. Block G, Patterson B, and Subar A: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18, 1-29, 1992.
9. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 2, 325-357, 1991.
10. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 2, 427-442, 1991.
11. Steinmetz KA and Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96, 1027-1039, 1996.
12. Skaper SD, Fabris M, Ferrari V, Dalle Carbonare M, and Leon A: Quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic Biol Med 22, 669-678, 1997.
13. Duthie SJ, Collins AR, Duthie GG, and Dobson VL: Quercetin and myricetin protect against hydrogen peroxide-induced DNA damage (strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat Res 393, 223-331, 1997.
14. Rice-Evans CA and Miller NJ: Antioxidant activities of flavonoids as bioactive components of food. Biochem Soc Trans 24, 790-795, 1996.
15. Sergediene E, Jonsson K, Szymusiak H, Tyrakowska B, Rietjens IM, et al.: Prooxidant toxicity of polyphenolic antioxidants to HL-60 cells: description of quantitative structure-activity relationships. FEBS Lett 462, 392-396, 1999.
16. Bravo L: Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317-333, 1998.
17. Holme SA, Varma S, Chowdhury MM, and Roberts DL: Audit of a melanoma screening day in the U.K.: clinical results, participant satisfaction and perceived value. Br J Dermatol 145, 784-788, 2001.
18. Serraino D, Fratino L, Gianni W, Campisi C, Pietropaolo M, et al.: Epidemiological aspects of cutaneous malignant melanoma (review). Oncol Rep 5, 905-909, 1998.
19. Hall HI, Miller DR, Rogers JD, and Bewerse B: Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 40, 35-42, 1999.
20. Schadendorf D, Worm M, Algermissen B, Kohlmus CM, and Czarnetzki BM: Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. Cancer 73, 103-108, 1994.
21. Helmbach H, Rossmann E, Kern MA, and Schadendorf D: Drug-resistance in human melanoma. Int J Cancer 93, 617-622, 2001.
22. Menon LG, Kuttan R, and Kuttan G: Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett 95, 221-225, 1995.
23. Menon LG, Kuttan R, Nair MG, Chang YC, and Kuttan G: Effect of isoflavones genistein and daidzein in the inhibition of lung metastasis in mice induced by B16F-10 melanoma cells. Nutr Cancer 30, 74-77, 1998.
24. Menon LG, Kuttan R, and Kuttan G: Anti-metastatic activity of curcumin and catechin. Cancer Lett 141, 159-165, 1999.
25. Lama G, Angelucci C, Bruzzese N, Iacopino F, Nori SL, et al.: Sensitivity of human melanoma cells to oestrogens, tamoxifen and quercetin: is there any relationship with type I and II oestrogen binding site expression?. Melanoma Res 8, 313-322, 1998.
26. Iwashita K, Kobori M, Yamaki K, and Tsushida T: Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells. Biosci Biotechnol Biochem 64, 1813-1820, 2000.
27. Gomez-Cordoves C, Bartolome B, Vieira W, and Virador VM: Effects of wine phenolics and sorghum tannins on tyrosinase activity and growth of melanoma cells. J Agric Food Chem 49, 1620-1624, 2001.
28. Marshall NJ, Goodwin CJ, and Holt SJ: A critical assessment of the use of microculture tetrazolium assays to measure cell growth and function. Growth Regul 5, 69-84, 1995.
29. Rooprai HK, Kandanearatchi A, Maidment SL, Christidou M, Trillo-Pazos G, et al.: Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol Appl Neurobiol 27, 29-39, 2001.
30. Nagao T, Abe F, and Okabe H: Antiproliferative constituents in the plants 7. Leaves of Clerodendron bungei and leaves and bark of C. trichotomum. Biol Pharm Bull 24, 1338-41, 2001.
31. Kampa M, Hatzoglou A, Notas G, Damianaki A, Bakogeorgou E, et al.: Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines. Nutr Cancer 37, 223-33, 2000.
32. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47, 936-942, 1987.
33. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of radiosensitivity. Cancer Res 47, 943-946, 1987.
34. Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, et al.: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48, 589-601, 1988.
35. Rodriguez-Vicente J, Vicente-Ortega V, and Canteras-Jordana M: The effects of different antineoplastic agents and of pretreatment by modulators on three melanoma lines. Cancer 82, 495-502, 1998.
36. Kuntz S, Wenzel U, and Daniel H: Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr 38, 133-142, 1999.
37. Sanchez I, Calderon J, Ruiz B, Tellez J, Calzada L, et al.: In vitro cytotoxicity of flavonoids against MK2 and C6 tumour cells. Phytother Res 15, 290-293, 2001.
38. Yin F, Giuliano AE, and Van Herle AJ: Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid 4, 369-376, 1999.
39. Wang C and Kurzer MS: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28, 236-247, 1997.
40. Zava DT and Duwe G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27, 31-40, 1997.
41. Guthrie N and Carroll KK: Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol 439, 227-236, 1998.
42. Le Bail JC, Varnat F, Nicolas JC, and Habrioux G: Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett 130, 209-216, 1998.
43. Delarue F, Kedjouar B, Mesange F, Bayard F, Faye JC, et al.: Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicity. Biochem Pharmacol 57, 657-661, 1999.
44. Caltagirone S, Ranelletti FO, Rinelli A, Maggiano N, Colasante A, et al.: Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. Am J Respir Cell Mol Biol 17, 51-59, 1997.
45. Kudo M, Naito Z, Yokoyama M, and Asano G: Effects of quercetin and sunphenon on responses of cancer cells to heat shock damage. Exp Mol Pathol 66, 66-75, 1999.
46. Casagrande F and Darbon JM: Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61, 1205-1215, 2001.
47. Gomez-Cordoves C, Bartolome B, Vieira W, and Virador VM: Effects of wine phenolics and sorghum tannins on tyrosinase activity and growth of melanoma cells. J Agric Food Chem 49, 1620-1624, 2001.
48. Rodriguez J, Yañez J, Vicente V, Alcaraz M, Benavente-Garcia O, et al.: Effects of several flavonoids on the growth of B16F10 and SK-MEL-1 melanoma cell lines: relationship between structure and activity. Melanoma Res 12, 99-107, 2002.
49. Martinez C, Yáñez J, Vicente V, Alcaraz M, Benavente-Garcia O, et al.: Effects of several polyhydroxylated flavonoids on the growth of B16F10 and Melan-a cell lines. Influence of the secuential oxidation state on the flavonoids skeleton. Melanoma Res 13, 3-9, 2003.
50. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, et al.: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87, 595-600, 2000.
51. Kandaswami C, Perkins E, Drzewiecki G, Soloniuk DS, and Middleton E Jr: Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anticancer Drugs 3, 525-530, 1992.
52. Hirano T, Abe K, Gotoh M, and Oka K: Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br J Cancer 72, 1380-1388, 1995.
53. Ohno T, Inoue M, and Ogihara Y: Cytotoxic activity of gallic acid against liver metastasis of mastocytoma cells P-815. Anticancer Res 21, 3875-3880, 2001.
54. Agullo G, Gamet-Payrastre L, Fernandez Y, Anciaux N, Demigné C, et al.: Comparative effects of flavonoids on the growth, viability and metabolism of a colonic adenocarcinoma cell line (HT29 cells). Cancer Letters 105, 61-70, 1996.
55. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, et al.: Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research 57, 2916-2921, 1997.
56. Huang YT, Hwang JJ, Lee PP, Ke FC, Huang JH, et al.: Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128, (5): 999-1010, 1999.
57. Kawaii S, Tomono Y, Katase E, Ogawa K, and Yano M: Effect of citrus flavonoids on HL-60 cell differentiation. Anticancer Res 19, 1261-1269, 1999.
58. Kawaii S, Tomono Y, Katase E, Ogawa K, and Yano M: Antiproliferative activity of flavonoids on several cancer cell lines. Biosci Biotechnol Biochem 63, 896-899, 1999.
59. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, et al.: Relationship between flavonoids structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649-1657, 1997.
60. Ohno Y, Fukuda K, Takemura G, Toyota M, Watanabe M, et al.: Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 10, 845-851, 1999.
61. Qiu X, Takemura G, Koshiji M, Hayakawa Y, Kanoh M, et al.: Gallic acid induces vascular smooth muscle cell death via hydroxyl radical production. Heart Vessels 15, 90-99, 2000.
62. Middleton E and Kandaswami C: The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In Harborne JH (ed). The Flavonoids: Advances in Research Since 1986. London, UK: Chapman and Hall, 1993, pp 619-652.